2-(Methoxycarbonyl)-6-nitrobenzoic acid, 95.0%, 100g

4-(1,2,4-Oxadiazol-3-yl)benzoic acid, 95%, 250mg

(R)-2-((6-((3-Amino-5-chlorophenyl)amino)-9-isopropyl-9H-purin-2-yl)amino)-3-methylbutan-1-ol, 97%, 1mg

4-(Hydroxymethyl)-1-methylpyrrolidin-2-one, 97.0%, 5g

ROTI®Nanoquant, 500 ml, 2000 assays (cuvettes)

(R)-2-Amino-3-(5-bromothiophen-2-yl)propanoic acid, 95.0%, 250mg

8-Methoxy-1H-benzo[d]azepin-2(3H)-one, 95.0%, 500mg

Rhodamine-12-dUTP, 50 µl, 50 nmol

2-Amino-2-cyanoacetamide, 95.0%, 500mg

3-Chloro-2,4-difluoroaniline, 97.0%, 25g

(4-Butoxy-2,3-difluorophenyl)boronic acid, 95.0%, 10g

4-o-Tolyloxy-piperidine, 97.0%, 1g

(S)-4-Hydroxy-2-(3-methoxypropyl)-3,4-dihydro-2H-thieno[3,2-e][1,2]thiazine-6-sulfonamide 1,1-dioxide, 95.0%, 5g